212 related articles for article (PubMed ID: 18313231)
1. Bone marrow stromal cells reduce ischemia-induced astrocytic activation in vitro.
Gao Q; Li Y; Shen L; Zhang J; Zheng X; Qu R; Liu Z; Chopp M
Neuroscience; 2008 Mar; 152(3):646-55. PubMed ID: 18313231
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow stromal cells induce BMP2/4 production in oxygen-glucose-deprived astrocytes, which promotes an astrocytic phenotype in adult subventricular progenitor cells.
Xin H; Li Y; Chen X; Chopp M
J Neurosci Res; 2006 Jun; 83(8):1485-93. PubMed ID: 16528751
[TBL] [Abstract][Full Text] [Related]
3. Sevoflurane postconditioning attenuates reactive astrogliosis and glial scar formation after ischemia-reperfusion brain injury.
Zhu YM; Gao X; Ni Y; Li W; Kent TA; Qiao SG; Wang C; Xu XX; Zhang HL
Neuroscience; 2017 Jul; 356():125-141. PubMed ID: 28501505
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte-Derived Estrogen Regulates Reactive Astrogliosis and is Neuroprotective following Ischemic Brain Injury.
Wang J; Sareddy GR; Lu Y; Pratap UP; Tang F; Greene KM; Meyre PL; Tekmal RR; Vadlamudi RK; Brann DW
J Neurosci; 2020 Dec; 40(50):9751-9771. PubMed ID: 33158962
[TBL] [Abstract][Full Text] [Related]
5. Bone marrow stromal cells increase astrocyte survival via upregulation of phosphoinositide 3-kinase/threonine protein kinase and mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathways and stimulate astrocyte trophic factor gene expression after anaerobic insult.
Gao Q; Li Y; Chopp M
Neuroscience; 2005; 136(1):123-34. PubMed ID: 16198497
[TBL] [Abstract][Full Text] [Related]
6. Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats.
Yang Q; Wang EY; Huang XJ; Qu WS; Zhang L; Xu JZ; Wang W; Tian DS
J Neurochem; 2011 Nov; 119(3):644-53. PubMed ID: 21883215
[TBL] [Abstract][Full Text] [Related]
7. Down-regulation of neurocan expression in reactive astrocytes promotes axonal regeneration and facilitates the neurorestorative effects of bone marrow stromal cells in the ischemic rat brain.
Shen LH; Li Y; Gao Q; Savant-Bhonsale S; Chopp M
Glia; 2008 Dec; 56(16):1747-54. PubMed ID: 18618668
[TBL] [Abstract][Full Text] [Related]
8. The effect of activated microglia on astrogliosis parameters in astrocyte cultures.
Röhl C; Lucius R; Sievers J
Brain Res; 2007 Jan; 1129(1):43-52. PubMed ID: 17169340
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of human dental pulp stem cells and human bone marrow-derived mesenchymal stem cells on ischemic human astrocytes in vitro.
Song M; Jue SS; Cho YA; Kim EC
J Neurosci Res; 2015 Jun; 93(6):973-83. PubMed ID: 25663284
[TBL] [Abstract][Full Text] [Related]
10. Salidroside Inhibits Reactive Astrogliosis and Glial Scar Formation in Late Cerebral Ischemia via the Akt/GSK-3β Pathway.
Dong C; Wen S; Zhao S; Sun S; Zhao S; Dong W; Han P; Chen Q; Gong T; Chen W; Liu W; Liu X
Neurochem Res; 2021 Apr; 46(4):755-769. PubMed ID: 33389472
[TBL] [Abstract][Full Text] [Related]
11. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration: key signaling pathway for astrogliosis in vivo?
Sriram K; Benkovic SA; Hebert MA; Miller DB; O'Callaghan JP
J Biol Chem; 2004 May; 279(19):19936-47. PubMed ID: 14996842
[TBL] [Abstract][Full Text] [Related]
12. Gp130-dependent astrocytic survival is critical for the control of autoimmune central nervous system inflammation.
Haroon F; Drögemüller K; Händel U; Brunn A; Reinhold D; Nishanth G; Mueller W; Trautwein C; Ernst M; Deckert M; Schlüter D
J Immunol; 2011 Jun; 186(11):6521-31. PubMed ID: 21515788
[TBL] [Abstract][Full Text] [Related]
13. CID1067700, a late endosome GTPase Rab7 receptor antagonist, attenuates brain atrophy, improves neurologic deficits and inhibits reactive astrogliosis in rat ischemic stroke.
Qin Y; He Y; Zhu YM; Li M; Ni Y; Liu J; Zhang HL
Acta Pharmacol Sin; 2019 Jun; 40(6):724-736. PubMed ID: 30315251
[TBL] [Abstract][Full Text] [Related]
14. Valproic Acid Inhibits Glial Scar Formation after Ischemic Stroke.
Gao X; Zeb S; He YY; Guo Y; Zhu YM; Zhou XY; Zhang HL
Pharmacology; 2022; 107(5-6):263-280. PubMed ID: 35316816
[TBL] [Abstract][Full Text] [Related]
15. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo.
Zhu Z; Zhang Q; Yu Z; Zhang L; Tian D; Zhu S; Bu B; Xie M; Wang W
Glia; 2007 Apr; 55(5):546-58. PubMed ID: 17243097
[TBL] [Abstract][Full Text] [Related]
16. Zinc finger E-Box binding homeobox 2 (ZEB2)-induced astrogliosis protected neuron from pyroptosis in cerebral ischemia and reperfusion injury.
Zhao Z; Hu X; Wang J; Wang J; Hou Y; Chen S
Bioengineered; 2021 Dec; 12(2):12917-12930. PubMed ID: 34852714
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of Ski decreased the reactive astrocytes proliferation in vitro induced by oxygen-glucose deprivation/reoxygenation.
Zhao X; Zhou KS; Li ZH; Nan W; Wang J; Xia YY; Zhang HH
J Cell Biochem; 2018 Jun; 119(6):4548-4558. PubMed ID: 29236326
[TBL] [Abstract][Full Text] [Related]
18. Relevance of astrocytic activation to reductions of astrocytic GABAA receptors.
Tateishi N; Shimoda T; Manako J; Katsumata S; Shinagawa R; Ohno H
Brain Res; 2006 May; 1089(1):79-91. PubMed ID: 16643860
[TBL] [Abstract][Full Text] [Related]
19. Astrocyte gp130 expression is critical for the control of Toxoplasma encephalitis.
Drögemüller K; Helmuth U; Brunn A; Sakowicz-Burkiewicz M; Gutmann DH; Mueller W; Deckert M; Schlüter D
J Immunol; 2008 Aug; 181(4):2683-93. PubMed ID: 18684959
[TBL] [Abstract][Full Text] [Related]
20. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.
Lorenzo PI; Martin Vazquez E; López-Noriega L; Fuente-Martín E; Mellado-Gil JM; Franco JM; Cobo-Vuilleumier N; Guerrero Martínez JA; Romero-Zerbo SY; Perez-Cabello JA; Rivero Canalejo S; Campos-Caro A; Lachaud CC; Crespo Barreda A; Aguilar-Diosdado M; García Fuentes E; Martin-Montalvo A; Álvarez Dolado M; Martin F; Rojo-Martinez G; Pozo D; Bérmudez-Silva FJ; Comaills V; Reyes JC; Gauthier BR
Theranostics; 2021; 11(14):6983-7004. PubMed ID: 34093866
[No Abstract] [Full Text] [Related]
[Next] [New Search]
